IRIS
BARGAGLI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.904
NA - Nord America 15.524
AS - Asia 4.768
SA - Sud America 1.207
AF - Africa 172
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 10
Totale 39.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.324
IT - Italia 4.541
GB - Regno Unito 3.424
IE - Irlanda 3.002
CN - Cina 1.467
SG - Singapore 1.398
SE - Svezia 1.337
RU - Federazione Russa 1.324
DE - Germania 1.110
BR - Brasile 1.095
FR - Francia 960
HK - Hong Kong 861
UA - Ucraina 776
FI - Finlandia 642
IN - India 288
VN - Vietnam 212
ES - Italia 185
CA - Canada 143
NL - Olanda 142
CZ - Repubblica Ceca 109
CI - Costa d'Avorio 88
TR - Turchia 84
AT - Austria 73
JP - Giappone 53
PL - Polonia 49
BD - Bangladesh 44
BE - Belgio 44
IR - Iran 40
PK - Pakistan 36
UZ - Uzbekistan 32
AU - Australia 31
IQ - Iraq 31
AR - Argentina 29
MX - Messico 29
KR - Corea 27
MA - Marocco 26
CH - Svizzera 24
PH - Filippine 22
ZA - Sudafrica 22
PT - Portogallo 21
EC - Ecuador 18
AE - Emirati Arabi Uniti 17
PE - Perù 17
SA - Arabia Saudita 16
AZ - Azerbaigian 15
RO - Romania 15
DK - Danimarca 14
GR - Grecia 14
IL - Israele 14
BG - Bulgaria 13
KZ - Kazakistan 13
CO - Colombia 12
EE - Estonia 12
EG - Egitto 12
LT - Lituania 11
LV - Lettonia 11
VE - Venezuela 11
JO - Giordania 10
KG - Kirghizistan 10
CL - Cile 9
EU - Europa 9
JM - Giamaica 9
LK - Sri Lanka 9
BO - Bolivia 8
ID - Indonesia 8
LB - Libano 8
NG - Nigeria 8
GE - Georgia 7
LA - Repubblica Popolare Democratica del Laos 7
MK - Macedonia 7
NO - Norvegia 7
AM - Armenia 6
HU - Ungheria 6
LU - Lussemburgo 6
PA - Panama 6
PY - Paraguay 6
AL - Albania 5
CY - Cipro 5
OM - Oman 5
TN - Tunisia 5
CR - Costa Rica 4
IS - Islanda 4
NZ - Nuova Zelanda 4
RS - Serbia 4
BY - Bielorussia 3
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
NP - Nepal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IM - Isola di Man 2
KH - Cambogia 2
KW - Kuwait 2
MY - Malesia 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 39.601
Salva come PNG Salva come JPEG
Città #
Southend 3.037
Dublin 2.962
Fairfield 2.071
Chandler 1.436
Santa Clara 1.289
Ashburn 1.193
Woodbridge 879
Singapore 835
Hong Kong 830
Siena 820
Seattle 743
Houston 729
Wilmington 695
Cambridge 629
Jacksonville 581
Beijing 529
Princeton 475
Helsinki 409
Ann Arbor 405
Milan 391
Munich 354
Lastra a Signa 349
Florence 275
New York 257
Dong Ket 184
Nanjing 177
Rome 165
Boardman 152
San Diego 151
Moscow 147
Shanghai 140
Dearborn 138
Bengaluru 132
Los Angeles 128
San Mateo 127
Málaga 121
London 101
Fremont 100
Turku 96
Abidjan 88
Nuremberg 85
Düsseldorf 82
Lauterbourg 79
São Paulo 78
Nanchang 73
Brno 67
Portsmouth 66
Council Bluffs 60
The Dalles 57
Menlo Park 55
Chicago 54
Washington 53
Dallas 50
Ottawa 50
Shenyang 50
Frankfurt am Main 48
Vienna 43
Brussels 42
Gavirate 41
Catania 40
San Francisco 40
Norwalk 39
Rio de Janeiro 39
Izmir 38
Guangzhou 37
Lappeenranta 37
Olomouc 37
Naples 34
Toronto 34
Hebei 33
Hangzhou 32
Redwood City 32
Brescia 30
Changsha 30
Kunming 29
Warsaw 29
Tashkent 27
Tianjin 27
Jinan 26
Padova 26
Tarazona 26
Belo Horizonte 25
Jiaxing 25
Newark 25
Tokyo 25
Bologna 24
Dhaka 24
Livorno 22
Stockholm 22
Agliana 21
Zhengzhou 21
Amsterdam 19
Brooklyn 19
Gießen 19
Lancaster 19
Phoenix 19
Prato 19
Paris 18
Porto Alegre 18
Brasília 17
Totale 26.576
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 982
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 337
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 323
Cytokine modulators in the treatment of sarcoidosis 303
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 254
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 241
Genetic mechanisms of critical illness in COVID-19 236
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 224
Peripheral biomarkers' panel for severe COVID-19 patients 224
Gorham-Stout disease management during pregnancy 221
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 218
Antirheumatic agents in covid-19: is IL-6 the right target? 218
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 216
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 214
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6 211
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 209
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 205
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 203
Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity 201
Exhaled nitric oxide in interstitial lung diseases 200
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 200
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 197
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 194
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 194
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 190
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype? 189
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 187
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 185
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 185
Pathogen-sugar interactions revealed by universal saturation transfer analysis 184
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 184
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 182
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 181
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 180
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 179
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline 178
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 176
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 176
Quality of life, anxiety and depression in Sarcoidosis 174
Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways 174
Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 172
Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer 172
A first update on mapping the human genetic architecture of COVID-19 171
Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia 170
The analysis of tryptase in serum of sarcoidosis patients 169
Mapping the human genetic architecture of COVID-19 168
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 167
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases 167
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 167
Prognostic bioindicators in severe COVID-19 patients 167
NK and NKT-like cells in granulomatous and fibrotic lung diseases 166
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 166
Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 165
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 165
Serum analysis of coagulation factors in IPF and NSIP 164
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 164
Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. 163
Fibrotic Lung Toxicity Induced by Hydroxycarbamide 161
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 160
Phenotypes of organ involvement in sarcoidosis 160
Sarcoidosis: a review for the internist 160
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 159
Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis 159
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 159
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre 158
Sarcoidosis with upper respiratory tract involvement 154
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. 154
Omalizumab treatment in Samter's triad: case series and review of the literature 154
Serum amyloid A in patients with idiopathic pulmonary fibrosis 152
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 152
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 151
Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases 151
Research highlights from the 2018 ERS International Congress: interstitial lung diseases 151
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 151
Extracorporeal Photopheresis in Lung Transplantation 151
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1 150
Serial KL-6 measurements in COVID-19 patients 150
Atypical HRCT manifestations of pulmonary sarcoidosis 149
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 148
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis 145
null 145
Assessment of cardiac involvement in sarcoidosis by echocardiography 145
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 145
Concentrations of major elements and mercury in unstimulated human saliva 144
Chitotriosidase activity in patients with interstitial lung disesaes 143
null 143
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 142
Proteome analysis of bronchoalveolar lavage in lung diseases 141
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 141
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 141
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 140
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small cell lung cancer: anlysis of risk factors. 140
Proteomic investigation of pulmonary sarcoidosis 140
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 140
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 140
Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis 139
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 139
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 138
SARS-CoV-2 in pleural fluid in a kidney transplant patient 137
Gardening in greenhouses as a risk factor for silicosis. 136
Totale 18.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020331 0 0 0 0 0 0 0 0 0 0 0 331
2020/20215.455 198 503 235 694 365 656 317 663 496 375 422 531
2021/20224.509 351 594 368 307 224 157 199 211 186 526 485 901
2022/20235.759 426 595 721 693 420 1.048 359 491 450 203 213 140
2023/20245.542 218 138 518 273 294 1.285 1.652 226 62 180 179 517
2024/202511.441 715 525 1.293 672 1.401 661 611 736 943 618 1.276 1.990
Totale 40.976